Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020

NEXT STORY
ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
PREV STORY
Worldwide Disposable Syringes Industry to 2026 – Key Drivers, Restraints and Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxil Provides Research and Development Update

author_avatar
NASDAQ Market News

VA San Diego Healthcare System Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients

author_avatar
NASDAQ Market News

Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

38% Objective Response Rate (ORR) demonstrated in 47 Metastatic Melanoma patients who were unsuccessfully ...

author_avatar
NASDAQ Market News